METHOD AND SYSTEM FOR DETERMINING WHETHER A DRUG WILL BE EFFECTIVE ON A PATIENT WITH A DISEASE
Patent №
US 8,097,469
Granted
2012-01-17
Filed 2010
Owner
BIODESIX INC.
Lab
—
AI components
2
ml · hardware
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
12661124
A process of determining whether a patient with a disease or disorder will be responsive to a drug, used to treat the disease or disorder, including obtaining a test spectrum produced by a mass spectrometer from a serum produced from the patient. The test spectrum may be processed to determine a relation to a group of class labeled spectra produced from respective serum from other patients having the or similar clinical stage same disease or disorder and known to have responded or not responded to the drug. Based on the relation of the test spectrum to the group of class labeled spectra, a determination may be made as to whether the patient will be responsive to the drug.
AI classification
Ownership
BIODESIX INC.
assignment · 448150155
Assignors
RODER, HEINRICH, TSYPIN, MAXIM, GRIGORIEVA, JULIA
On an employer assignment, the assignors are typically the inventors.